跳至主要内容
临床试验/NCT00679419
NCT00679419Unknown不适用

Coronary Artery Disease and Renal Failure Registry

Institut für Klinisch-Kardiovaskuläre Forschung GmbH32 个研究点 分布在 1 个国家目标入组 3,352 人开始时间: 2007年12月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
3,352
试验地点
32
主要终点
all cause mortality

研究概览

简要总结

It is the aim of the multi-centric and prospective registry to analyze in patients with CAD the impact of different grades of renal failure on the outcome and course of the patients and to correlate these with clinical variables.

In particular, the registry has the following objectives:

  • prospective consecutive assessment of all patients with coronary artery disease and renal failure in the participating hospitals of the registry
  • evaluation of the outcome and course of patients with regard to their different stages of renal failure at baseline
  • analysis of the impact of different therapeutic strategies on acute and long-term outcomes
  • identification of clinical risk factors, novel biomarkers and genetic markers for an unfavorable long-term outcome

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Women and men >= 18 years of age
  • Patients with actually performed interventional coronary angiography and there a documented coronary heart disease, defined as at least one documented stenosis >= 50 % in at least one main coronary vessel (Main steam; RCX; RIVA; RCA)
  • European/Caucasian descent (European/Caucasian parents and grandparents)
  • Availability of an urine, serum- and EDTA blood sample of the patient
  • Documented consent of patients for handling of personal medical data, including a genetic analysis

排除标准

  • Patients who have been already recruited into this registry
  • Patients with organ transplantations, apart from kidney transplantations
  • Immunosuppressive therapy, apart from immunosuppressive therapy after kidney transplantation
  • Patients with polycystic renal disease
  • Pregnant and breastfeeding patients
  • Known malignant tumor

结局指标

主要结局

all cause mortality

时间窗: two years

次要结局

  • manner of death(two years)

研究者

发起方
Institut für Klinisch-Kardiovaskuläre Forschung GmbH
申办方类型
Network

研究点 (32)

Loading locations...

相似试验